• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
IIN

IIN

IntriCon Corporation

NASDAQHealthcareMedical - Instruments & SuppliesUS

USD24.23

+0.03 (+0.12%)

Company Profile

CEO

Mark Gorder

IPO Date

1980-03-17

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Exchange

NASDAQ

Country

US

Market Metrics

Open

$24.21

Prev. Close

$24.20

Day Low

$24.21

Day High

$24.23

52W Low

$12.47

52W High

$24.93

Volume

0.20M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

14.5%

Avg Negative

4.0%

Avg Neutral

81.5%

News Feed

VPG vs. IIN: Which Stock Should Value Investors Buy Now?

Zacks Investment Research·7/13/2021·↓ negative

3 Reasons Why IntriCon Corporation (IIN) Is a Great Growth Stock

Zacks Investment Research·5/12/2021·↑ positive

IntriCon Corporation (IIN) CEO Scott Longval on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/10/2021·↓ negative

Intricon to Announce 2021 First Quarter Results on Monday, May 10, 2021

GlobeNewsWire·4/26/2021·↑ positive

TTDKY vs. IIN: Which Stock Should Value Investors Buy Now?

Zacks Investment Research·4/6/2021·↓ negative

IntriCon Corporation (IIN) CEO Scott Longval on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·2/26/2021·↓ negative

Intricon Reports Fourth Quarter and Full Year 2020 Results

GlobeNewsWire·2/25/2021·↑ positive

Analysts Estimate IntriCon Corporation (IIN) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research·2/18/2021·↑ positive

Intricon to Announce 2020 Fourth Quarter and Full Year Results on Thursday, February 25, 2021

GlobeNewsWire·2/11/2021·↑ positive

Intricon Corporation Announces Appointment of Chief Financial Officer

GlobeNewsWire·2/8/2021·↑ positive